Photobiomodulation (Valeda Light Therapy) for Dry Macular Degeneration
- Home
- General
Photobiomodulation (Valeda Light Therapy) for Dry Macular Degeneration
Living with dry age-related macular degeneration (AMD) can be frustrating, especially when you notice gradual changes in your central vision. While lifestyle changes and nutritional supplements continue to play an important role, advances in retinal care have introduced new treatment options for eligible patients.
Photobiomodulation is an innovative, light-based therapy designed to support retinal cell function in patients with intermediate dry AMD. At phRETINA, Retina Specialist Dr. Paul Hahn, MD, PhD, FASRS, offers treatment using the Valeda Light Delivery System, helping patients explore evidence-based options for protecting their vision.
Schedule a Comprehensive Retinal Evaluation
Why Consider Photobiomodulation?
Unlike injections or surgery, Photobiomodulation is a non-invasive treatment performed in the office using carefully controlled wavelengths of light. For eligible patients, it offers an additional option for managing dry age-related macular degeneration before the disease progresses to more advanced stages. Patients may consider Photobiomodulation therapy because it offers:
- FDA-authorized treatment for eligible patients with dry AMD
- Non-invasive, light-based therapy
- No injections or surgery
- Generally painless treatment sessions
- No downtime after each visit
- Convenient in-office care
- Personalized treatment recommendations from our retina specialist
Every patient is different. A comprehensive retinal evaluation and advanced imaging are essential to determine whether this treatment is appropriate for your condition.
What Is Photobiomodulation?
Photobiomodulation is an advanced treatment that uses specific wavelengths of visible and near-infrared light to support the function of retinal cells affected by dry age-related macular degeneration.
Think of your retinal cells like rechargeable batteries. As dry AMD progresses, these cells gradually become less efficient at producing the energy needed to maintain healthy vision. Photobiomodulation therapy delivers carefully controlled light energy to help support normal cellular activity and retinal health.
Rather than replacing damaged retinal tissue, Photobiomodulation eye treatment is designed to help existing retinal cells function more efficiently. This makes it a promising option for selected patients with intermediate dry AMD.
What Is Valeda Light Therapy?
If you've searched for Valeda Light Therapy, Valeda treatment, or Valeda eye treatment, you're referring to treatment delivered using the Valeda Light Delivery System.
Valeda is the first FDA-authorized system that uses Photobiomodulation to treat eligible patients with dry age-related macular degeneration. During treatment, the device delivers carefully controlled wavelengths of light to the retina in a series of short, non-invasive office visits.
Unlike laser procedures, injections, or surgery, Valeda treatment is gentle and does not damage retinal tissue. Instead, it is designed to support normal retinal cell function using light energy.
How Does Valeda Work?
A common question patients ask is, "How does Valeda work?"
The retina relies on healthy cells to capture light and send visual information to the brain. As dry AMD develops, these cells become less efficient over time.
Valeda Photobiomodulation works by delivering precise wavelengths of light to retinal cells. This light helps support normal cellular activity and energy production, which may improve visual function in eligible patients with dry AMD.
Treatment is provided over a series of scheduled office visits, allowing our retina specialist to monitor your retinal health and response throughout the process.
Who Is Eligible for Valeda?
One of the most common questions we hear is, "Who is eligible for Valeda?"
You may be a candidate if you:
- Have intermediate dry age-related macular degeneration
- Have been evaluated by a retina specialist
- Meet the clinical treatment criteria for the Valeda system
- Have retinal imaging that supports treatment eligibility
- Are looking for a non-invasive treatment option
Not every patient with macular degeneration will qualify. If you have advanced geographic atrophy involving the center of the macula or active wet AMD, another treatment approach may be more appropriate.
A comprehensive retinal examination is the best way to determine whether Photobiomodulation for dry AMD is right for you.
What to Expect During Treatment
Your care begins with a comprehensive retinal evaluation performed by Dr. Paul Hahn. During this visit, our retina specialist will review your medical history, evaluate your vision, and perform advanced retinal imaging to determine whether Photobiomodulation for macular degeneration is appropriate for your condition.
If you're eligible, your treatment plan will include a series of scheduled office visits using the Valeda Light Delivery System.
During each session:
- You'll sit comfortably while the device delivers controlled light to your retina.
- The treatment is non-invasive and generally painless.
- No injections, incisions, or anesthesia are required.
- Sessions are completed in a relatively short amount of time.
- Most patients can return to their normal daily activities immediately afterward.
Throughout your treatment, our retina specialist will continue monitoring your retinal health to ensure you receive personalized, evidence-based care.
Benefits of Photobiomodulation
For eligible patients with dry age-related macular degeneration, Photobiomodulation offers a non-invasive treatment designed to support retinal health and visual function. While individual results vary, treatment may provide meaningful benefits when recommended by our retina specialist.
Potential benefits include:
- Non-invasive treatment with no surgery or injections
- Supports retinal cell function
- May improve visual function in eligible patients
- May enhance contrast sensitivity
- Short, in-office treatment sessions
- No downtime after treatment
- Personalized care based on your retinal condition
Our retina specialist will determine whether light therapy for dry AMD is appropriate based on your retinal imaging, overall eye health, and stage of disease.
Is Photobiomodulation Painful?
One of the most common questions patients ask is whether Photobiomodulation is painful.
The answer is no. Photobiomodulation is generally painless and is designed to be comfortable for most patients.
Unlike injections or surgery, Valeda eye treatment does not involve needles, incisions, or anesthesia. During treatment, you'll simply sit comfortably while the Valeda system delivers carefully controlled light to your retina.
Some patients notice bright lights or flashes during the procedure, which is expected. After each session, you can typically return to your normal daily activities without any recovery time.
Is Valeda FDA Authorized?
Many patients also ask, "Is Valeda FDA approved?"
The Valeda Light Delivery System is the first FDA-authorized Photobiomodulation treatment for eligible patients with dry age-related macular degeneration.
Its authorization is based on clinical evidence evaluating its safety and effectiveness for its intended use. However, not every patient with dry AMD is a candidate, which is why a comprehensive retinal evaluation is essential before beginning treatment.
Our retina specialist will carefully assess your retinal health and determine whether Valeda treatment is the right option for you.
Why Choose Dr. Paul Hahn?
Choosing the right retina specialist is just as important as choosing the right treatment.
Dr. Paul Hahn, MD, PhD, FASRS, is a board-certified retina specialist with extensive experience treating all stages of macular degeneration. He combines advanced diagnostic technology with personalized, evidence-based care to help patients make informed decisions about their eye health.
Why patients trust Dr. Hahn:
- Fellowship-trained in vitreoretinal surgery
- Over 9 years of surgical experience in retina care
- Led more than 30 clinical trials in retinal disease treatment
- Known for a clear, respectful approach to patient communication
- Offers state-of-the-art diagnostics and therapies in Nanuet, NY
Whether you're newly diagnosed with dry AMD or exploring advanced treatment options like Photobiomodulation, Dr. Hahn provides individualized care focused on protecting your vision for the future.
Why Choose phRETINA?
At phRETINA, we believe every patient deserves expert, personalized retinal care backed by the latest advancements in ophthalmology.
Our practice combines physician-led expertise, advanced diagnostic technology, and evidence-based treatments to create care plans tailored to each patient's needs. From your initial consultation through every stage of treatment, our goal is to help you make confident decisions about your vision.
Physician-Led Retinal Care
Every treatment plan is guided directly by Dr. Paul Hahn's expertise.
Advanced Diagnostic Technology
Advanced retinal imaging and diagnostic technology support accurate evaluation.
Individualized Treatment Recommendations
Care plans are tailored to each patient's specific retinal condition and goals.
Access to Innovative Therapies
Including Photobiomodulation, alongside other evidence-based treatments.
Compassionate Care
A comfortable clinical setting focused on patient comfort throughout treatment.
Conveniently Located
Our practice is conveniently located in Nanuet, NY.
Helpful Information for New and Returning Patients
Ready to Learn if Photobiomodulation Is Right for You?
Schedule a comprehensive retinal evaluation with Dr. Paul Hahn and the phRETINA team today.